Literature DB >> 25351655

Hereditary thyroid cancer syndromes and genetic testing.

Kathryn J Rowland1, Jeffrey F Moley.   

Abstract

This review focuses on both hereditary medullary thyroid cancer (MTC) and hereditary nonmedullary thyroid cancer (NMTC) and discusses the genetics, clinical diagnosis and evaluation, and surgical approach to treatment of these malignancies. Areas of innovation as well as areas of debate are highlighted and management recommendations are made.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  hereditary thyroid cancer; medullary thyroid cancer; multiple endocrine neoplasia; nonmedullary thyroid cancer; ret proto oncogene

Mesh：

Year:  2014        PMID： 25351655     DOI： 10.1002/jso.23769

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  8 in total

1.  Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.

Authors:  Aida Orois; Celia Badenas; Jordi L Reverter; Verónica López; Miriam Potrony; Mireia Mora; Irene Halperin; Josep Oriola
Journal:  Horm Cancer       Date:  2020-03-14       Impact factor: 3.869

2.  Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.

Authors:  Kalin Vidinov; Dragomira Nikolova
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

3.  Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.

Authors:  Anish Jacob Cherian; Pooja Ramakant; Rekha Pai; Marie Therese Manipadam; S Elanthenral; Anuradha Chandramohan; Julie Hephzibah; David Mathew; Dhukabandhu Naik; Thomas V Paul; Simon Rajaratnam; Nihal Thomas; M J Paul; Deepak Thomas Abraham
Journal:  Indian J Surg Oncol       Date:  2017-12-08

4.  Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.

Authors:  Jingan Zhou; Preeti Singh; Kanhua Yin; Jin Wang; Yujia Bao; Menghua Wu; Kush Pathak; Sophia K McKinley; Danielle Braun; Carrie C Lubitz; Kevin S Hughes
Journal:  Ann Surg Oncol       Date:  2021-03-03       Impact factor: 5.344

5.  The clinicopathologic characteristics of familial and sporadic papillary thyroid carcinoma in Turkish patients

Authors:  Havva Sezer; Mehmet Onur Demirkol; Dilek Yazici; Yersu Kapran; Mahmut Faruk Alagöl
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

6.  NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.

Authors:  Aida Orois; Sudheer K Gara; Mireia Mora; Irene Halperin; Sandra Martínez; Rocio Alfayate; Electron Kebebew; Josep Oriola
Journal:  Genes (Basel)       Date:  2019-11-07       Impact factor: 4.096

7.  A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.

Authors:  Talia L Fuchs; Anthony J Nassour; Anthony Glover; Mark S Sywak; Stan B Sidhu; Leigh W Delbridge; Roderick J Clifton-Bligh; Matti L Gild; Venessa Tsang; Bruce G Robinson; Adele Clarkson; Amy Sheen; Loretta Sioson; Angela Chou; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2020-10       Impact factor: 6.298

8.  Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Wei Liu; Tao Hong; Xiaodong He
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.